Common Contracts
5 similar Patent License Agreement contracts by Cellectis S.A.
PATENT LICENSE AGREEMENT n° C-00061906Patent License Agreement • March 12th, 2019 • Cellectis S.A. • Biological products, (no disgnostic substances)
IP is owner of patents and patent applications relating to a method of homologous recombination. IP has already granted exploitation rights for these patents and patent application to third parties for specific applications and now wishes to share this technology with a new industrial partner.
PATENT LICENSE AGREEMENT n° C-00061905Patent License Agreement • March 12th, 2019 • Cellectis S.A. • Biological products, (no disgnostic substances)
IP filed two provisional patents applications in the United States whom inventors are Mr. Richard Mulligan and Mr. André Choulika relating to process of homologous recombination using meganucleases. IP has agreed to share with BCH exploitation rights of the inventions of theses patent applications and now wishes to share its rights under this technology with a industrial partner.
PATENT LICENSE AGREEMENT n° C-00061901Patent License Agreement • March 12th, 2019 • Cellectis S.A. • Biological products, (no disgnostic substances)
IP is the owner with both UPMC and the Institut Curie and CNRS of patents and patent applications relating to the gene of enzyme I-SceI, the expression of the enzyme I-SceI and its use. The LICENSOR has already granted exploitation rights for these patents and patent application to Third Parties for specific applications and now wishes to hare this technology with a new industrial partner.
PATENT LICENSE AGREEMENT n° C-00061901Patent License Agreement • March 12th, 2015 • Cellectis S.A. • Biological products, (no disgnostic substances)
IP is the owner with both UPMC and the Institut Curie and CNRS of patents and patent applications relating to the gene of enzyme I-SceI, the expression of the enzyme I-SceI and its use. The LICENSOR has already granted exploitation rights for these patents and patent application to Third Parties for specific applications and now wishes to hare this technology with a new industrial partner.
PATENT LICENSE AGREEMENT n° C-00061906Patent License Agreement • March 12th, 2015 • Cellectis S.A. • Biological products, (no disgnostic substances)
IP is owner of patents and patent applications relating to a method of homologous recombination. IP has already granted exploitation rights for these patents and patent application to third parties for specific applications and now wishes to share this technology with a new industrial partner.
